# Use of Nitroglycerine to Improve Signs of Poor Peripheral Perfusion in Patients With Traumatic Hemorrhagic Shock

> **NCT03235921** · PHASE2 · UNKNOWN · sponsor: **Assiut University** · enrollment: 100 (estimated)

## Conditions studied

- Hemorrhagic Shock

## Interventions

- **DRUG:** Nitroglycerin patch 5mg
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT03235921
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-03
- **Primary completion:** 2017-08
- **Final completion:** 2017-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03235921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03235921, "Use of Nitroglycerine to Improve Signs of Poor Peripheral Perfusion in Patients With Traumatic Hemorrhagic Shock". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03235921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*